Denver Investment Advisors LLC raised its position in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) by 0.1% during the second quarter, Holdings Channel reports. The firm owned 691,079 shares of the company’s stock after buying an additional 733 shares during the period. Phibro Animal Health Corporation comprises 1.1% of Denver Investment Advisors LLC’s investment portfolio, making the stock its 11th largest position. Denver Investment Advisors LLC’s holdings in Phibro Animal Health Corporation were worth $25,604,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of PAHC. Vanguard Group Inc. boosted its stake in Phibro Animal Health Corporation by 8.2% in the first quarter. Vanguard Group Inc. now owns 1,729,406 shares of the company’s stock worth $48,597,000 after buying an additional 130,935 shares during the period. Wellington Management Group LLP raised its position in shares of Phibro Animal Health Corporation by 0.9% in the first quarter. Wellington Management Group LLP now owns 1,385,325 shares of the company’s stock worth $38,928,000 after buying an additional 11,950 shares in the last quarter. State Street Corp raised its position in shares of Phibro Animal Health Corporation by 6.1% in the first quarter. State Street Corp now owns 489,093 shares of the company’s stock worth $13,745,000 after buying an additional 28,273 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of Phibro Animal Health Corporation by 12.3% in the first quarter. Dimensional Fund Advisors LP now owns 396,007 shares of the company’s stock worth $11,128,000 after buying an additional 43,260 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of Phibro Animal Health Corporation by 13.3% in the first quarter. Bank of New York Mellon Corp now owns 347,657 shares of the company’s stock worth $9,769,000 after buying an additional 40,735 shares in the last quarter. Hedge funds and other institutional investors own 47.64% of the company’s stock.

Phibro Animal Health Corporation (PAHC) opened at 39.75 on Tuesday. Phibro Animal Health Corporation has a 1-year low of $20.14 and a 1-year high of $40.25. The stock has a market capitalization of $1.58 billion, a price-to-earnings ratio of 24.69 and a beta of 1.35. The firm has a 50-day moving average of $38.09 and a 200-day moving average of $32.39.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 27th. Stockholders of record on Wednesday, September 6th will be given a $0.10 dividend. The ex-dividend date of this dividend is Friday, September 1st. This represents a $0.40 annualized dividend and a dividend yield of 1.01%. Phibro Animal Health Corporation’s dividend payout ratio is presently 24.69%.

TRADEMARK VIOLATION NOTICE: “Denver Investment Advisors LLC Has $25.60 Million Position in Phibro Animal Health Corporation (PAHC)” was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece can be viewed at https://www.watchlistnews.com/denver-investment-advisors-llc-has-25-60-million-position-in-phibro-animal-health-corporation-pahc/1490709.html.

A number of brokerages recently weighed in on PAHC. Piper Jaffray Companies set a $35.00 price target on shares of Phibro Animal Health Corporation and gave the company a “buy” rating in a research note on Friday, July 21st. BidaskClub lowered shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, June 14th. Zacks Investment Research raised shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a research note on Thursday, May 11th. Finally, Credit Suisse Group lowered shares of Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and raised their price target for the company from $29.00 to $36.00 in a research note on Friday, June 2nd. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $30.50.

In other Phibro Animal Health Corporation news, insider Jack Bendheim sold 48,000 shares of the stock in a transaction that occurred on Thursday, May 25th. The shares were sold at an average price of $34.67, for a total transaction of $1,664,160.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, major shareholder Bfi Co., Llc sold 16,000 shares of the stock in a transaction that occurred on Wednesday, July 5th. The stock was sold at an average price of $36.98, for a total transaction of $591,680.00. Following the transaction, the insider now directly owns 28,000 shares in the company, valued at approximately $1,035,440. The disclosure for this sale can be found here. Insiders sold 352,000 shares of company stock worth $12,599,200 over the last quarter. Company insiders own 48.09% of the company’s stock.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corporation (NASDAQ:PAHC).

Institutional Ownership by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.